Insight Article Desktop Banner
June 18, 2020
Coronavirus: Fundamental weaknesses begin to hit home
Insight Video Mobile Banner
June 18, 2020

Coronavirus: Fundamental weaknesses begin to hit home


Coronavirus: Fundamental weaknesses begin to hit home

Share Icon

June 18, 2020


The concerns that we have discussed over many weeks appear to be starting to play out. We have consistently stated our belief that the market is over optimistic given the risk of a second wave of COVID-19. This is particularly true now for the US, which we believe is re-opening prematurely, even as cases are surging across the country. Previously hidden economic weaknesses are also revealing themselves, such as an increasing number of bankruptcies in the US. The recent spike in volatility, with the VIX reaching levels in the mid-40s1, indicates that markets appear now to recognise these factors.


In recent weeks we have only changed the broad asset mix of our portfolios to help maintain target volatility. Our underlying fundamental view has remained consistent and this week we have reduced exposure to risk assets. A nuance is that, while lowering risk overall, we have tilted the risk we do take to regions that are more cautious with respect to virus controls than the US, where the second wave is most likely to cause more disruption.

Tactical Positioning

We have removed our underweights to Eurozone Equities, Japanese Equities and European High Yield and our overweights to US 10-Year Treasuries, Consumer Staples and Brazilian Equities. Overall in terms of risk assets we continue to favour regions with better virus controls and prefer credit over equities, deeming the latter to be more expensive. Whilst our analysis indicates that credit is not cheap, it is showing better pricing than equities.

Eurozone Equities

We have moved Eurozone equities from underweight to neutral, relative to other equity regions. The European tourism industry is opening faster than expected, so the hit to GDP may be less severe than anticipated, and generally cautious virus controls lessen the risk of a re-escalation of COVID-19 cases. In addition, Europe’s high exposure to cyclicals has been a headwind over the past few months, but this could become a tailwind during the eventual recovery. Whilst earnings in Europe are below 2016 levels, we believe analysts may be too bearish.

Historically, the EU has struggled to implement a co-ordinated and robust policy response. However, we are positively surprised by the latest support, including the €750bn EU Recovery Fund, which was larger than expected, and the ECB’s extension of the Pandemic Emergency Purchase Programme to at least mid-2021.

Japanese Equities

Last week we moved from underweight Japanese Equities back to neutral. Whilst we believed that monetary stimulus was already in full force, we were previously concerned that Japan lacked sufficient fiscal support. However, recent fiscal measures have put Japan on a par with other Developed Markets. For example, their short-term support for employees is being rolled out in a more substantial way. Our previous positioning had also been prompted by the fact that Japan was one of the first countries outside China with cases of COVID-19, but it appears now to have credible measures to contain the virus.  

There are also some fundamental factors which could help Japan in comparison to other Developed Markets. Whilst some of these factors appear to be priced in, they are structural and remain attractive in this environment. For example, high labour shortages reported in recent years have likely prevented firms from dismissing workers, reducing the likelihood of an immediate rise in unemployment.

We believe that one of the sectors which is likely to see the slowest recovery is tourism, to which Japan has lower exposure than either the EU or US. In addition, Japanese Equities 2021 PEs is cheaper than it was at the end of 20192, suggesting that their recent outperformance has not translated into inflated valuations.

Finally, Japan’s dividend resilience is a further positive. More than half of Japanese companies have a positive net cash position, compared with around 20% of companies in the US and Europe, meaning Japan has more robust dividend paying capacity3. Japanese companies also have the potential to buffer earnings shocks given a low payout ratio historically compared with the US and Europe3.

European High Yield

We moved underweight to neutral European High Yield based on a number of factors. With respect to fundamentals we believe that Europe is likely to suffer the biggest hit to GDP globally in 2020. However, this headwind should be partially offset by the robust policy response. As economies start to recover, EU High Yield fund flows, which have so far been muted compared with US High Yield, should slowly increase. Finally, the spread relationship between US High Yield and EU High Yield tends to be stable and this has held even throughout the COVID-19 crisis. Since the sell-off in March, US High Yield and EU High Yield spreads have compressed and we believe that US High Yield will continue to receive substantial central bank support and remain stable. Given that the spread relationship between US and US High Yield has neared its mean-reverting levels, this suggests EU High Yield is also likely to remain stable around current levels.

US 10-Year Treasuries

This is another tactical move which we believe has now run its course, so we have moved from overweight to neutral. We initially made the move to overweight as we expected US Treasuries to continue to benefit from a flight-to-quality and lower rates priced in by Fed funds futures4 . Furthermore, at the time the risk-off sentiment and dampened consumer confidence we believed was likely to continue to support sentiment towards US Treasuries.

This trade has played out as we expected, with US Treasuries mitigating the downside better than most other fixed income asset classes. US Treasuries continue to outperform and whilst there may be more upside, we see this as an opportunity to rotate into assets such as credit, which still have room for recovery. As mentioned, whilst credit is no longer cheap, our analysis suggests valuations are close to fair. Equities appear to be expensive, indicating that equity markets have front-run the recovery.

Consumer Staples

Over the past month performance has shifted with defensives selling off and cyclicals performing well. Whilst Consumer Staples are likely to continue to deliver stable earnings, this is significantly priced in and a case for an overweight no longer holds. Moreover when the recovery does occur, this asset class will probably underperform. For this reason we have moved our position in Consumer Staples from overweight to neutral.

Brazilian Equities

We also moved from overweight Brazilian Equities to neutral last week. Since we made the initial move to overweight, Brazilian Equities and the Real have moved substantially higher, suggesting that now the near-term upside is limited. Brazil was one of the few economies in the world which began reopening, even as cases of COVID-19 climbed. However, there has since been a surge in new cases and the parts of Brazil’s economy that were reopening are having to backtrack. The combination of the sharp rally and the growing risk of a renewed lockdown has led us to close out this tactical position.


Last week we trimmed our position in gold to take profit as the asset reached price levels that we had envisioned. The trimming in overall risk exposure reduces the need for the gold hedge and its price is now relatively high. However, renewed US-China tensions, the potential for a second wave and signs of fundamental weakness in the economy, support the case to maintain a position in gold for diversification.

Tactical Preferences
We have provided an overview of our latest tactical views below:

Source: MSIM GBaR team, as of 15 June 2020. For informational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The tactical views expressed above are a broad reflection of our team’s views and implementations, expressed for client communication purposes.



1 The VIX reached 43 on 12 June, 13:00. This is provided for illustrative purposes only and is not meant to depict the volatility of a specific investment.

2 Datastream, IBES, 3 June 2020.

3 Goldman Sachs Global Investment Research, Factset. Comparing the US, Europe and Japan payout ratio since 1993.

4 Fed funds futures reflect the market’s view of the Federal Reserve’s future changes to the fed funds rate. 



Diversification neither assures a profit nor guarantees against loss in a declining market.

There is no assurance that the Strategy will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market values of securities owned by the portfolio will decline and that the value of portfolio shares may therefore be less than what you paid for them.  Market values can change daily due to economic and other events (e.g. natural disasters, health crises, terrorism, conflicts and social unrest) that affect markets, countries, companies or governments. It is difficult to predict the timing, duration, and potential adverse effects (e.g. portfolio liquidity) of events.  Accordingly, you can lose money investing in this portfolio. Please be aware that this strategy may be subject to certain additional risks. There is the risk that the Adviser’s asset allocation methodology and assumptions regarding the Underlying Portfolios may be incorrect in light of actual market conditions and the Portfolio may not achieve its investment objective. Share prices also tend to be volatile and there is a significant possibility of loss. The portfolio’s investments in commodity-linked notes involve substantial risks, including risk of loss of a significant portion of their principal value. In addition to commodity risk, they may be subject to additional special risks, such as risk of loss of interest and principal, lack of secondary market and risk of greater volatility, that do not affect traditional equity and debt securities. Currency fluctuations could erase investment gains or add to investment losses. Fixed-income securities are subject to the ability of an issuer to make timely principal and interest payments (credit risk), changes in interest rates (interest-rate risk), the creditworthiness of the issuer and general market liquidity (market risk). In a rising interest-rate environment, bond prices may fall and may result in periods of volatility and increased portfolio redemptions. In a declining interest-rate environment, the portfolio may generate less income. Longer-term securities may be more sensitive to interest rate changes.Equity and foreign securities are generally more volatile than fixed income securities and are subject to currency, political, economic and market risks. Equity values fluctuate in response to activities specific to a company. Stocks of small-capitalization companies carry special risks, such as limited product lines, markets and financial resources, and greater market volatility than securities of larger, more established companies. The risks of investing in emerging market countries are greater than risks associated with investments in foreign developed markets.  Exchange traded funds (ETFs) shares have many of the same risks as direct investments in common stocks or bonds and their market value will fluctuate as the value of the underlying index does. By investing in exchange traded funds ETFs and other Investment Funds, the portfolio absorbs both its own expenses and those of the ETFs and Investment Funds it invests in. Supply and demand for ETFs and Investment Funds may not be correlated to that of the underlying securities. Derivative instruments can be illiquid, may disproportionately increase losses and may have a potentially large negative impact on the portfolio’s performance.  A currency forward is a hedging tool that does not involve any upfront payment. The use of leverage may increase volatility in the Portfolio. Diversification does not protect you against a loss in a particular market; however, it allows you to spread that risk across various asset classes. 

Managing Director
Global Balanced Risk Control Team
Managing Director
Global Balanced Risk Control Team
Executive Director


The indexes shown in this report are not meant to depict the performance of any specific investment, and the indexes shown do not include any expenses, fees or sales charges, which would lower performance. The indexes shown are unmanaged and should not be considered an investment. It is not possible to invest directly in an index.

VIX: This is a trademarked ticker symbol for the Chicago Board Options Exchange Market Volatility Index, a popular measure of the implied volatility of S&P 500 Index options. Often referred to as the fear index or the fear gauge, it represents one measure of the market’s expectation of stock market volatility over the next 30-day period.

EPS: Earnings per share is the portion of a company’s profit allocated to each outstanding share of common stock.


The views and opinions are those of the author as of the date of publication and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all portfolio managers at Morgan Stanley Investment Management (MSIM) or the views of the firm as a whole, and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific Morgan Stanley Investment Management product.

Except as otherwise indicated, the views and opinions expressed herein are those of the portfolio management team, are based on matters as they exist as of the date of preparation and not as of any future date, and will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date hereof.

Certain information herein is based on data obtained from third party sources believed to be reliable. However, we have not verified this information, and we make no representations whatsoever as to its accuracy or completeness.

The information herein is a general communications which is not impartial and has been prepared solely for information and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy.


The material contained herein has not been based on a consideration of any individual client circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Past performance is no guarantee of future results. Charts and graphs provided herein are for illustrative purposes only.

This communication is not a product of Morgan Stanley’s Research Department and should not be regarded as a research recommendation. The information contained herein has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This commentary is only intended for, and will be only distributed to, persons resident in jurisdictions where distribution or availability would not be contrary to local laws or regulations.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the product’s relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.


This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

EMEA: This communication has been issued by Morgan Stanley Investment Management Limited (“MSIM”). Authorised and regulated by the Financial Conduct Authority. Registered in England No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

Ireland: Morgan Stanley Investment Management (Ireland) Limited. Registered Office: The Observatory, 7-11 Sir John Rogerson’s, Quay, Dublin 2, Ireland. Registered in Ireland under company number 616662. Regulated by the Central Bank of Ireland. United Kingdom: Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA, authorised and regulated by the Financial Conduct Authority. Dubai: Morgan Stanley Investment Management Limited (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). Germany: Morgan Stanley Investment Management Limited Niederlassung Deutschland, Grosse Gallusstrasse 18, 60312 Frankfurt am Main, Germany (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Italy: Morgan Stanley Investment Management Limited, Milan Branch (Sede Secondaria di Milano) is a branch of Morgan Stanley Investment Management Limited, a company registered in the U.K., authorised and regulated by the Financial Conduct Authority (FCA), and whose registered office is at 25 Cabot Square, Canary Wharf, London, E14 4QA. Morgan Stanley Investment Management Limited Milan Branch (Sede Secondaria di Milano) with seat in Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy, is registered in Italy with company number and VAT number 08829360968. The Netherlands: Morgan Stanley Investment Management, Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. Telephone: 31 2-0462-1300. Morgan Stanley Investment Management is a branch office of Morgan Stanley Investment Management Limited. Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Switzerland: Morgan Stanley & Co. International plc, London, Zurich Branch, authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-115.415.770. Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland. Telephone +41 (0) 44 588 1000. Facsimile Fax: +41(0)44 588 1074.

Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong.


A separately managed account may not be appropriate for all investors. Separate accounts managed according to the strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain a prospectus, please download one at or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley Funds.


Singapore: This publication should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore (“SFA”), (ii) to a “relevant person” (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. This publication has not been reviewed by the Monetary Authority of Singapore.

Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accepts responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act.

Taiwan: This material is provided for information purposes only and does not constitute a solicitation where such a solicitation is unlawful. The products mentioned herein this material may or may not have been registered with the Securities and Futures Bureau of the Financial Supervisory Commission in Taiwan, Republic of China (“ROC”) pursuant to relevant securities laws and regulations. Such products may only be made available in the ROC if they are (a) registered for public sale in the ROC or (b) availed on a private placement basis to specified financial institutions and other entities and individuals meeting specific criteria pursuant to the private placement provisions of the ROC Rules Governing Offshore Funds.

Korea: This material is not, and under no circumstances is to be construed as an offering of securities in Korea. No representation is being made with respect to the eligibility of any recipients of this material under the laws of Korea, including but without limitation, the Foreign Exchange Transaction Law and Regulations thereunder. The Fund’s mentioned herein this material may or may not have been registered with the Financial Services Commission of Korea under the Financial Investment Services and Capital Markets Act and may not be offered directly or indirectly, in Korea or to any resident of Korea except pursuant to applicable laws and regulations of Korea.

Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.20% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association, The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.

The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without MSIM’s express written consent.

All information contained herein is proprietary and is protected under copyright law.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.

​This document may be translated into other languages. Where such a translation is made this English version remains definitive. If there are any discrepancies between the English version and any version of this document in another language, the English version shall prevail.


It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.